CDEK by Data4ThePeople
Sign in Sign up
← All organizations

SIGA Technologies

For profitContributed to NMEWebsite ↗

Also known as: SIGA Chief Scientific Officer | SIGA Technologies | SIGA TECHNOLOGIES | SIGA Technologies Chief Scientific Officer | SIGA Technologies, Inc.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Feb 1, 2007

First marketed drug

Jul 13, 2018

First NDA

Jul 13, 2018

Last known activity

Sep 12, 2022

Timeline

1990s

  1. Jul 1, 1995

    SIGA Technologies— Founded

2010s

  1. Jul 13, 2018

    tecovirimat— NDA Organization

  2. Jul 13, 2018

    tecovirimat— NDA Secondary Org

Drugs by trial phase (2 distinct, 10 trials)

Phase 4 (1 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (1)

Recent trials (15)

Details

Founded
New York, NY, US Jul 1, 1995
First NDA
Jul 13, 2018
Last known activity
Sep 12, 2022

Designations held

  • Orphan drug
  • Fast track
  • Priority review